tezosentan has been researched along with bay 41-8543 in 1 studies
Studies (tezosentan) | Trials (tezosentan) | Recent Studies (post-2010) (tezosentan) | Studies (bay 41-8543) | Trials (bay 41-8543) | Recent Studies (post-2010) (bay 41-8543) |
---|---|---|---|---|---|
157 | 29 | 33 | 44 | 0 | 32 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hedelin, P; Kylhammar, D; Lundgren, J; Rådegran, G | 1 |
1 other study(ies) available for tezosentan and bay 41-8543
Article | Year |
---|---|
sGC stimulation totally reverses hypoxia-induced pulmonary vasoconstriction alone and combined with dual endothelin-receptor blockade in a porcine model.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelin Receptor Antagonists; Enzyme Activators; Female; Guanylate Cyclase; Hypertension, Pulmonary; Hypoxia; Lung; Morpholines; Pyridines; Pyrimidines; Receptors, Endothelin; Swine; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasodilator Agents | 2012 |